| abstract |
The invention relates to a substantially water-free pharmaceutical composition comprising a combination of the components acetylsalicylic acid, or a physiologically acceptable salt, or a physiologically acceptable ester thereof (component (A)), at least one C 2-4 -aliphatic, monohydric alcohol (component (B)), at least one at least dihydric alcohol (component (C)), at least one compound selected from the group consisting of sugar substitutes and sugar substituents (component (D)), and optionally one or more further physiologically acceptable auxiliary agents as further component(s). |